PubMed ID

15057297

UMMS Affiliation

Center for Infectious Disease and Vaccine Research

Date

4-2-2004

Document Type

Article

Subjects

Dengue; Dengue Virus; Humans; Immune System; Vaccines

Disciplines

Clinical Epidemiology | Immunology and Infectious Disease | Pharmacy and Pharmaceutical Sciences

Abstract

Dengue is an expanding public health problem, and an effective vaccine remains elusive. This review discusses how the significant influence of sequential infection with different dengue virus serotypes on the severity of disease can be viewed in terms of beneficial and detrimental effects of heterologous immunity. A more complete understanding of these effects is likely to be critical for predicting optimal vaccine-induced immune responses.

Rights and Permissions

Citation: J Clin Invest. 2004 Apr;113(7):946-51. Link to article on publisher's site

Related Resources

Link to Article in PubMed

 
 

To view the content in your browser, please download Adobe Reader or, alternately,
you may Download the file to your hard drive.

NOTE: The latest versions of Adobe Reader do not support viewing PDF files within Firefox on Mac OS and if you are using a modern (Intel) Mac, there is no official plugin for viewing PDF files within the browser window.